P30CA051008 (WEINER, LOUIS M.)Sep 30, 1990 - Apr 30, 2029 NIH Georgetown University Lombardi Comprehensive Cancer Center Support Grant Role: Co-Principal Investigator |
|
K08CA062008 (PESTELL, RICHARD G)Sep 30, 1994 - Sep 29, 1997 NIH TRANSCRIPTIONAL REGULATION OF THE CG GENES IN CANCER Role: Principal Investigator |
|
P30CA056036 (CHAPMAN, ANDREW)Jun 22, 1995 - May 31, 2029 NIH Translational Research in Cancer Role: Co-Principal Investigator |
|
R29CA070896 (PESTELL, RICHARD G)May 15, 1996 - Feb 28, 2001 NIH REGULATION OF CYCLIN D1 EXPRESSION Role: Principal Investigator |
|
R01CA070896 (PESTELL, RICHARD G)May 15, 1996 - Jul 31, 2012 NIH Regulation of cyclin D1 Expression Role: Principal Investigator |
|
R55CA075503 (PESTELL, RICHARD G)Sep 15, 1997 - May 31, 1998 NIH BREAST INDUCIBLE ANTISENSE CYCLIN D1 TRANSGENIC MICE Role: Principal Investigator |
|
R01CA075503 (PESTELL, RICHARD G)Jun 5, 1998 - Jul 31, 2013 NIH Initiation and Maintenance in Mammary Tumorigenesis Role: Principal Investigator |
|
C06RR014567 (PESTELL, RICHARD G)Sep 30, 1999 - Dec 31, 2003 NIH EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION PROJECTS Role: Principal Investigator |
|
R01CA086072 (PESTELL, RICHARD G)Apr 1, 2000 - Aug 28, 2014 NIH Androgen Receptor Function in Prostate Cancer Role: Principal Investigator |
|
R01CA093596 (PESTELL, RICHARD G)Dec 11, 2001 - Nov 30, 2007 NIH Caveolin-1 and Cyclin D1 in Mammary Tumorigenesis Role: Principal Investigator |
|
R01CA107382 (PESTELL, RICHARD G)Jul 2, 2004 - Apr 30, 2010 NIH Cyclin D1 Regulation of Nuclear Receptor Function in Breast Cancer Role: Principal Investigator |
|
S10RR023661 (PESTELL, RICHARD G)May 15, 2007 - May 14, 2008 NIH Automated High Throughput DNA Sequencer Role: Principal Investigator |
|
R01CA132115 (PESTELL, RICHARD G)Dec 1, 2007 - Jun 30, 2020 NIH DACH1/Eya Cell fate determination factor and mammary tumorigenesis Role: Principal Investigator |
|
R01CA137494 (PESTELL, RICHARD G)Aug 1, 2010 - Jan 31, 2016 NIH Impact of Cyclin D1 Isoforms in Breast Cancer Role: Principal Investigator |
|
R21CA235139 (PESTELL, RICHARD G)Sep 1, 2020 - Aug 31, 2022 NIH CCR5 inhibitors to enhance therapeutic response of breast cancer to DNA damaging agents Role: Principal Investigator |